Repeat and Relapsing Peritonitis Microbiological Trends and Outcomes: A 21-Year Single-Center Experience

Table 1

Clinical characteristics of the repeat/relapsing and control group at the time of peritonitis.

	Repeat/relapsing group (N = 36)	Control group (N = 77)	value
Age, media [IQR]	58, [47, 63.8]	55 [42, 64.5]	0.64
Male sex, n, %	21, 58.3%	46, 59.7%	0.89
CAPD, n, %	26, 72.2%	54, 70.1%	0.82
CKD cause			0.49
Glomerulonephritis, n%	14, 38.9%	32, 41.6%
Diabetes, n%	3, 8.3%	18, 23.3%
Polycystic kidney disease, n%	3, 8.3%	8, 10.4%
Obstruction, n%	2, 5.6%	6, 7.8%
Others/unknown, n%	14, 38.8%	13, 16.8%
Major comorbidities
Coronary heart disease, n%	4, 11.1%	13, 16.9%	0.42
Peripheral arterial disease, n%	1, 2.8%	8, 10.4%	0.16
Cerebrovascular disease, n%	5, 13.9%	5, 6.5%	0.20
Diabetes mellitus, n%	3, 8.3%	18, 23.3%	0.06

CAPD—continuous ambulatory peritoneal dialysis; CKD—chronic kidney disease; IQR—interquartile range.